Dr. Eva del Amo has received the best publication award of 2020 from European Journal of Pharmaceutics and Biopharmaceutics (EJPB). The awarded publication is a collaborative study with the University of Santiago de Compostela, IDIS and SERGAS, Spain. The study shows for the first time quantitative pharmacokinetic analysis in the rat eyes with positron emission tomography/computed tomography (PET/CT).
Dr. Eva del Amo was also a co-author in the awarded publication in 2019 (EJPB Best Paper Award). This publication investigated mechanistically the routes of drug elimination from the eye.
”These awards demonstrate increasing interest in ocular drug treatment and ophthalmic pharmacokinetics. Of course, this is personally very encouraging,” Dr. del Amo says.
Dr. del Amo is a senior researcher in the ocular drug delivery group led by professor Arto Urtti at the School of Pharmacy, University of Eastern Finland.
Original articles:
Andrea Luaces-Rodríguez, Eva M del Amo, Cristina Mondelo-García, Noemí Gómez-Lado, Francisco Gonzalez, Álvaro Ruibal, Miguel González-Barcia, Irene Zarra-Ferro, Francisco J. Otero-Espinar, Anxo Fernández-Ferreiro, Pablo Aguiar. PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats. European Journal of Pharmaceutics and Biopharmaceutics, 154 (2020) 330-337.
https://doi.org/10.1016/j.ejpb.2020.06.024
Eva Ramsay, Marja Hagström, Kati-Sisko Vellonen, Susanna Boman, Elisa Toropainen, Eva M. del Amo, Heidi Kidron, Arto Urtti, Marika Ruponen. Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation. European Journal of Pharmaceutics and Biopharmaceutics, 143 (2019) 18-23.
https://doi.org/10.1016/j.ejpb.2019.08.008
Intravitreal injections are widely used in the retinal drug delivery, for example in age related macular degeneration treatment. Image: Eva del Amo.
